FdaApplication

NDA 021864

Back to search

Identifiers

Properties

PropertyValue
applicant_nameWYETH PHARMACEUTICALS INC
application_typeNDA
approval_date2007-05-22

Products (1)

ProductActive ingredientStrengthDosage form
LYBRELETHINYL ESTRADIOL; LEVONORGESTREL0.02MG;0.09MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

1 product